MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,630,262 | -20.0% | 24,858 | +26.6% | 0.00% | -25.0% |
Q2 2023 | $4,536,147 | +44.7% | 19,637 | +51.8% | 0.00% | +33.3% |
Q1 2023 | $3,134,360 | +49.7% | 12,938 | -27.7% | 0.00% | +50.0% |
Q1 2021 | $2,094,000 | +5.2% | 17,900 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,990,000 | -8.4% | 17,900 | -2.2% | 0.00% | 0.0% |
Q3 2020 | $2,173,000 | +8.4% | 18,300 | +3.4% | 0.00% | 0.0% |
Q2 2020 | $2,005,000 | +84.3% | 17,700 | +8.6% | 0.00% | +100.0% |
Q1 2020 | $1,088,000 | -27.6% | 16,300 | -1.2% | 0.00% | 0.0% |
Q4 2019 | $1,503,000 | +24.5% | 16,500 | +17.9% | 0.00% | 0.0% |
Q3 2019 | $1,207,000 | +84.6% | 14,000 | +124.4% | 0.00% | 0.0% |
Q2 2019 | $654,000 | -4.0% | 6,238 | +14.7% | 0.00% | 0.0% |
Q1 2019 | $681,000 | +9.1% | 5,438 | -1.8% | 0.00% | 0.0% |
Q4 2018 | $624,000 | -72.8% | 5,538 | -48.3% | 0.00% | -66.7% |
Q3 2018 | $2,295,000 | +38.9% | 10,718 | +81.4% | 0.00% | +50.0% |
Q2 2018 | $1,652,000 | +265.5% | 5,908 | +52.7% | 0.00% | +100.0% |
Q1 2018 | $452,000 | – | 3,868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PACIFIC VIEW ASSET MANAGEMENT, LLC | 25,070 | $2,825,000 | 3.32% |
HealthCor Management, L.P. | 688,890 | $77,652,000 | 2.43% |
Avoro Capital Advisors LLC | 225,000 | $25,362,000 | 1.52% |
EMORY UNIVERSITY | 17,038 | $1,921,000 | 1.51% |
Rock Springs Capital Management LP | 241,000 | $27,166,000 | 1.28% |
Baker Brothers Advisors | 1,169,278 | $131,801,000 | 1.08% |
Caption Management, LLC | 100,800 | $11,362,000 | 0.91% |
SHIKIAR ASSET MANAGEMENT INC | 14,341 | $1,617,000 | 0.84% |
Pier Capital, LLC | 37,654 | $4,244,000 | 0.84% |
Atika Capital Management LLC | 20,000 | $2,254,000 | 0.66% |